Published in Cancer Weekly, June 17th, 2003
The new and improved formulations include pharmaceutically acceptable, water miscible solubilizers other than Cremophor which are believed to have improved long-term stability and may reduce adverse side-effects relative to existing formulations.
"Paclitaxel is poorly soluble in water, so Cremophor is used to help the drug dissolve," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.